171 results on '"Sanguineti G"'
Search Results
2. MRI-BASED ATLAS OF PROSTATIC BED RECURRENCE IN PROSTATE CANCER PATIENTS: CONSISTENCY IN RELATION TO CTV GUIDELINES
3. WORSENING OF 2-YEAR PATIENT-REPORTED INTESTINAL FUNCTIONALITY AFTER RADIOTHERAPY FOR PROSTATE CANCER INCLUDING PELVIC NODE IRRADIATION
4. ASSOCIATION OF PERSISTENT URINARY SYMPTOMS WITH QUALITY OF LIFE AFTER PROSTATE CANCER RADIOTHERAPY
5. INFLUENCE OF THE 4D ROBUST PLANNING APPROACH ON THE COMPARISON BETWEEN PHOTON AND PROTON FOR THE TREATMENT OF STAGE III LUNG CANCER: A DOSIMETRIC AND RADIOBIOLOGICAL STUDY
6. DCE-MRI-Based Atlas for Prostate Bed Recurrence after Radical Prostatectomy: Consistency of CTV Delineation with the Available Contouring Guidelines
7. SBRT in 3 Fractions for T1 Glottic Cancer
8. 5-Year Results from a Prospective Phase II Trial of Ten-Fractions Hypofractionated Radiotherapy in Locally Advanced Breast Cancer
9. OC-0426 Immunomonitoring in prostate cancer patients treated with 3 different radiotherapy strategies
10. MO-0220 Two-year impact of bowel symptoms on HRQoL after RT for prostate cancer with pelvic node irradiation
11. MO-0215 Incidence and predictors of lower extremity lymphedema after post-prostatectomy radiotherapy
12. PD-0076 Radiotherapy Treatment Interruptions Management: An Italian Survey
13. PO-1483 Persistent urinary symptoms and long-term quality of life after prostate cancer radiotherapy
14. The Prognostic Value of the Size and the Sub-Site of the Local Failure at DCE-MRI before Salvage Radiotherapy for Prostate Cancer
15. OC-0457 Modeling outcome after salvage post-prostatectomy radiotherapy: impact of pelvic nodes irradiation
16. PD-0414 Trend over time of patient-reported QoL domains after pelvic nodal irradiation for prostate cancer
17. OC-0766 Response of local disease at magnetic resonance after salvage radiotherapy for prostate cancer
18. PD-0415 Pelvic RT in prostate cancer: late intestinal toxicity is modulated by severity of acute symptoms
19. Consolidative active scanning proton therapy for mediastinal lymphoma: selection criteria, treatment implementation and clinical feasibility
20. Comparison of rigid and deformable co-registration between mpMRI and CT images in radiotherapy of prostate bed recurrence
21. Setting up an Italian end-to-end dosimetric audit for IMRT and VMAT: the experience of the OPRORA project
22. Immunomonitoring During Radiotherapy of Prostate Cancer: Effect of Dose & Volume on Peripheral Immune Cells
23. Ten Fraction Adjuvant Hypofractionated Radiotherapy in Node Positive Breast Cancer: 3 Year-Follow-Up of a Phase II Toxicity Study
24. PH-0660 Independent role of dose-escalation and prophylactic WPRT in salvage RT after radical prostatectomy
25. PD-0769 Patient-reported acute intestinal toxicity and impact on patient QoL after WPRT for prostate cancer
26. PH-0108 New dose-volume constraints for patient-reported acute bowel toxicity symptoms in whole pelvis IMRT
27. PO-1342 Trends and predictors of worsening at RT end of anxiety and depression during RT for prostate cancer
28. PO-1345 Symptoms affecting Emotional, Systemic and Social Domains 2 years after RT for prostate cancer
29. PO-1354 Time Dependence of PSADT prognostic threshold in men treated with post-prostatectomy salvage RT
30. PD-0767 Predictors of urinary incontinence 2 years after RT with different intents for prostate cancer
31. PD-0782 Predicting bRFS after salvage post-prostatectomy RT with a “one-size-fits-all” TCP-based formula
32. PO-0961 Role of depth of infiltration (DOI) as independent prognostic factor in pT1--T2 N0 oral tongue SCC
33. Independent role of dose-escalation and prophylactic lymph-nodal irradiation in salvage radiotherapy after prostatectomy. A retrospective, multi-institute analysis on 725 men treated with high-dose radiotherapy and eight years follow-up
34. A prospective study assessing the post-prostatectomy detection rate of a presumed local failure at mpMR with 18F-choline, 64Cu-Cl2 or 64Cu-PSMA PET/CT
35. Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis
36. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group
37. PD-0059: Patient-reported baseline incontinence at post-prostatectomy RT: its dependence on time from surgery
38. PD-0668: Longitudinal analysis of patient-reported urinary incontinence 2yr after post-prostatectomy RT
39. PH-0366: Predictors of incontinence 2yr after post-prostatectomy RT: evidence of dose & fractionation effects
40. Improved survival of patients with advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy
41. Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives
42. PO-0850 Comparison of self-reported acute urinary incontinence in pts treated with adjuvant or salvage IMRT
43. EP-1531 SBRT for Prostate Cancer in 3 fractions: Acute Toxicity Rates from a Prospective Multicenter Study
44. EP-1567 Prospective longitudinal evaluation of quality of life after prostate cancer IMRT
45. PO-0851 Quality of life after whole pelvis RT for prostate cancer: results from a prospective study
46. Comparison of self-reported acute urinary incontinence in patients treated with adjuvant or salvage post-prostatectomy intensity modulated-radiotherapy (IMRT)
47. Dose-effect relationship for 1-year incontinence after post-prostatectomy intensity-modulated radiotherapy (MRT)
48. A new lateral cervical approach for salvage total laryngo-pharyngectomy
49. 113. Eligibility and feasibility of adjuvant breast cancer treatments with pencil beam scanning (PBS) proton therapy. An inter-institutional study
50. 202. Quantitative evaluation and optimization of daily on-line shift in prostate cancer treatment using control charts
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.